A Standing Insurer-Hospital Panel and Benchmark Treatment Rates Are Both on the Table. Read Them Before the Next Group Mediclaim Renewal

On 10 August 2026 The Economic Times reported that the General Insurance Council's chief executive had floated a standing insurer-hospital panel to resolve disputes, and the paper carried the same proposal again on 19 August 2026. Two days after the first report, Reuters reported that India plans insurance reforms aimed at reining in healthcare costs, and Livemint and Outlook Business described the shape of the work: a reform panel chaired by IRDAI weighing standardised treatment rates agreed between insurers and hospitals, and a nationwide claims exchange built on the National Health Claims Exchange. Recommendations are expected by the end of 2026. Outlook Money covered the same package on 16 August 2026.

None of this is new ground. In 2025 the General Insurance Council pushed a common empanelment plan modelled on Ayushman Bharat, which ThePrint described on 10 September 2025 while insurers and large private hospitals were openly at war. Outlook Business reported on 21 August 2025 that private hospitals opposed the proposal, and The Indian Express reported on 28 August 2025 that hospitals accused the insurers' body of cartelisation after cashless treatment was suspended at some chains. The 2026 version differs in one respect that matters: the chair is the regulator rather than the industry body.

Outlook Business on 12 August 2026 put three numbers around the reform work. Health premiums were Rs 1.17 trillion in FY 2024-25. Medical inflation is cited at 12 to 14% annually. And an estimated 10 to 15% of claims may be unwarranted.

Read those together and the logic of standard rates becomes visible. If a tenth to a seventh of claims spend is unwarranted, and if a meaningful part of that is the same procedure billed at very different prices depending on who is paying, then a published rate card compresses that variance without touching clinical volume. That is a real saving, and it is also a bounded one.

What it does not touch is utilisation. Medical inflation of 12 to 14% is a blend of provider price increases, consumables and drug costs, technology substitution towards more expensive modalities, and more admissions per covered life. Standard rates act on price. They do not act on how many people go to hospital, how long they stay, or whether the admission was needed at all.

Why that split decides your renewal answer

A group mediclaim renewal loading is built from your incurred claims over the expiring year. If your claims cost rose because your covered population used more hospital care, benchmark rates in 2027 or 2028 change very little for you. If it rose because a handful of network hospitals billed your insured employees at rates well above what the same hospital accepts from a government scheme or a corporate tie-up, a rate card is directly relevant. Decomposing your own claims register on that axis is work you can do now, and it is covered in more detail in our note on decomposing a GMC renewal loading against published medical trend.

The General Insurance Council's segment-wise report upto July 2026 sets the commercial context an employer negotiates inside. For April to July of FY 2026-27, group health gross direct premium was Rs 29,731.94 crore, up 14.9% year on year. Retail health over the same months was Rs 20,380.50 crore, up 31.6%.

Group remains the bigger segment by a wide margin, but retail is growing at roughly twice the rate. That matters for two reasons at a renewal table.

1. Insurers writing rapid retail growth have less need to defend an underperforming group account, so the appetite spread between carriers widens and testing the market is more likely to produce a genuinely different answer.
2. Group health is where the price variance the reform panel is targeting concentrates, because group cover carries the highest sums insured, the widest network access and the lowest member cost sensitivity. Any standard-rate regime will be felt in group before it is felt in retail.

Segment-wise GDPI measures written premium. It describes market direction and carrier appetite. Your own loss experience is a separate figure that only your claims register answers, so treat these numbers as an input to the decision on whether to market the account.

Split the renewal quote into parts and ask, for each, whether an agreed rate card between insurers and hospitals would move it.

Parts benchmark rates would compress:

• Package rates for common planned procedures at network hospitals, where the current spread between what a hospital accepts from different payers is widest.
• Differential billing on the same procedure between an insured patient and a cash or scheme patient, which is the specific grievance the 2025 empanelment fight was about.
• Disputes over what is a reasonable and customary charge, because a published rate supplies an external reference where today the phrase is argued case by case.

Parts they would not touch:

• Admission volume and length of stay, which is where utilisation growth sits.
• Non-payable consumables and items excluded by the policy, which shift cost onto the employee rather than the insurer and are governed by the policy schedule, not by hospital pricing.
• Your own demographic mix, dependant enrolment and plan design drift, all of which change the risk independent of provider price.
• Care taken outside the network, and care at hospitals that decline to sign up to whatever rate framework emerges. Private hospital participation is precisely what collapsed the 2025 proposal.

The honest conclusion is that a standard-rate regime is a claims-cost control measure with a partial reach. Treating it as a coming answer to a 20 to 35% renewal loading would be a planning error.

While the reform panel works, the operative document is your policy wording. Three clauses do most of the work in a network-hospital billing dispute, and most employers have never read them. Two of them are below; the third, the preferred provider network clause, is the subject of the next section.

Reasonable and customary charges

Almost every Indian group mediclaim wording limits payment to charges that are reasonable and customary for the geography and the nature of the illness. It is the clause the insurer relies on when it pays less than the hospital billed. In the absence of a published benchmark, the insurer's own reference table decides the number, and that table is rarely shared with the policyholder. Ask for it. An insurer that will not disclose its package rates at the hospitals your employees actually use is asking you to accept an unpriced exclusion in practice.

The non-payable items list

Consumables, gloves, administrative charges and a long tail of similar items sit on a non-payable list. When they are disallowed, the employee pays them at discharge. A group policy that looks generous on sum insured can still leave a meaningful out-of-pocket figure at the counter, and HR hears about that, not about the loss ratio.

Many wordings now carve out a preferred provider network where a higher share of the bill is payable, or where the insurer has negotiated fixed package rates. This clause is the closest thing to benchmark pricing that exists today, and it is already contractual rather than aspirational. If your insurer runs one, the list of hospitals and the package rates inside it are the single most useful disclosure you can obtain at renewal.

An industry forum whose recommendations are due at the end of 2026 will not help an employer renewing in November 2026. Contractual commitments will. Put these on the renewal checklist and require written answers before binding.

1. Pre-authorisation turnaround, expressed in hours with a measurement definition. Ask what clock starts on receipt of a complete request, what counts as complete, and what the insurer's own performance was on your account over the expiring year. A turnaround commitment without a measurement definition is not a commitment.
2. A named escalation route on differential billing. When an employee is billed at a rate the insurer will not accept, someone has to resolve it while the patient is still admitted. Ask for a named desk, a response time, and a rule on who carries the disputed amount in the interim. Do not accept a generic grievance address.
3. Disclosure of package rates at your top network hospitals. Take the six to ten hospitals that generate the bulk of your claims and ask for the agreed package rates at each for your most frequent procedures. If the insurer treats this as confidential, record that answer, because it tells you how much of your renewal loading you can ever verify.
4. Claims data in a usable format, monthly. Procedure-level, hospital-level, with the disallowed amount shown separately from the paid amount. Without hospital-level detail you cannot tell price variance from utilisation, which is the whole question this reform cycle turns on.
5. NHCX participation. Ask whether your insurer and your third-party administrator are live on the National Health Claims Exchange for your policy, and for which transaction types. Star Health's managing director told Moneycontrol on 21 August 2026 that the exchange can become the UPI for health insurance claims. Whether or not that comparison holds, the operational question of who is actually transacting on it is answerable today, and it is covered in our broker operations guide to rebuilding the claims desk around NHCX.

Each of these is a term you can hold an insurer to during the policy year. None of them depends on what the reform panel recommends in December.

Three things would tell you the reform work is becoming real rather than remaining a proposal.

The first is private hospital participation. The 2025 common empanelment plan died because large private chains refused it and cashless was suspended at some of them, which The Indian Express reported on 28 August 2025 alongside cartelisation allegations against the insurers' body. If the 2026 process produces a rate framework that major chains sign, it has cleared the obstacle that stopped the last one. If hospital associations are still issuing opposition statements in December, it has not.

The second is the form the output takes. A standing dispute panel constituted by the General Insurance Council is an industry arrangement. An IRDAI circular, or a rate framework every insurer has to build into a filed wording, is regulation. The first is negotiable by the parties. The second binds them, and it is the version that would actually reach a group mediclaim wording.

The third is what happens to the non-payable items list. A rate card that fixes procedure prices while leaving consumables and administrative charges outside it moves cost onto the employee at discharge rather than removing it. Whether the reform package addresses the disallowed tail is the clearest test of whether it is aimed at total cost of care or only at the insurer's share of it.

Until those resolve, the useful posture for an employer is unchanged: know your own split between price variance and utilisation, get the three network clauses read against your actual hospital list, and convert the commitments you want into policy terms rather than waiting for an industry body to deliver them. Our note on the provider economics behind FY27 group health renewals sets out the cost base insurers are pricing against.